Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.

Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J.

J Affect Disord. 2002 Apr;68(2-3):317-30.

PMID:
12063159
4.

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

Ravindran AV, Guelfi JD, Lane RM, Cassano GB.

J Clin Psychiatry. 2000 Nov;61(11):821-7.

PMID:
11105734
5.

A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients.

Markowitz JC, Kocsis JH, Bleiberg KL, Christos PJ, Sacks M.

J Affect Disord. 2005 Dec;89(1-3):167-75. Epub 2005 Nov 2.

PMID:
16263177
6.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
7.

Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.

Barrett JE, Williams JW Jr, Oxman TE, Frank E, Katon W, Sullivan M, Hegel MT, Cornell JE, Sengupta AS.

J Fam Pract. 2001 May;50(5):405-12.

PMID:
11350703
8.

Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.

Kragh-Sørensen P, Müller B, Andersen JV, Buch D, Stage KB.

J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):24S-30S.

PMID:
7593726
9.

A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.

Rocca P, Marchiaro L, Rasetti R, Rivoira E, Bogetto F.

Psychiatry Res. 2002 Oct 10;112(2):145-52.

PMID:
12429360
10.

Moclobemide versus fluoxetine for double depression: a randomized double-blind study.

Duarte A, Mikkelsen H, Delini-Stula A.

J Psychiatr Res. 1996 Nov-Dec;30(6):453-8.

PMID:
9023788
11.

Solving interpersonal problems correlates with symptom improvement in interpersonal psychotherapy: preliminary findings.

Markowitz JC, Bleiberg KL, Christos P, Levitan E.

J Nerv Ment Dis. 2006 Jan;194(1):15-20.

PMID:
16462550
12.
14.

Moclobemide versus fluoxetine in the treatment of inpatients with major depression.

Gattaz WF, Vogel P, Kick H, Kohnen R.

J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):35S-40S.

PMID:
7593728
15.
16.

A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.

Stabl M, Kasas A, Blajev B, Bajetta G, Zöchling R, Holsboer-Trachsler E, Realini R, Schäublin-Loidl M.

J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):41S-45S. Erratum in: J Clin Psychopharmacol 1995 Oct;15(5):360.

PMID:
7593730
18.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
19.

Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.

Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.

Acta Psychiatr Scand Suppl. 1990;360:48-9.

PMID:
2248070
20.

Open comparative randomised study of moclobemide versus amitriptyline in major depressive illness (DSM IIIR) in Nigeria.

Ononye F, Sijuola OA, Chukwuani CM, Mume OC, Makanjuola RO.

West Afr J Med. 2000 Apr-Jun;19(2):148-53.

PMID:
11070752

Supplemental Content

Support Center